BIOLIFE SOLUTIONS INC (BLFS) Earnings Signals & AI Vibe Check

Latest Filing: 10-K  |  Filed Feb 26, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for BIOLIFE SOLUTIONS INC?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, BIOLIFE SOLUTIONS INC's filing signal turned positive.
earningsVibe SuperAnalyst™ Verdict: TURNED POSITIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-16.46%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Positive
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Continuing Positive

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does BIOLIFE SOLUTIONS INC actually do?
Answer:
BioLife Solutions, Inc. is a life sciences company specializing in bioproduction products and services designed to enhance the quality and de-risk the manufacturing, distribution, and transportation of cell and gene therapies. The company's core offerings include proprietary biopreservation media, such as HypoThermosol(R) FRS and CryoStor(R) Freeze Media, which are formulated to maintain cell health and viability during hypothermic and cryogenic storage. BioLife also provides human platelet lysate media for cell expansion, closed-system cell processing containers, and automated thawing devices like the ThawSTAR(R) line. These products are utilized in both research and commercial manufacturing within the rapidly expanding cell and gene therapy market. The company operates as a single reportable segment, focusing on organic growth, partnerships, and strategic acquisitions to expand its product platforms.
Question:
What are BIOLIFE SOLUTIONS INC's revenue drivers?
Answer:
Revenue is primarily driven by the sale of biopreservation media and cell processing tools. The company's products are used in research and commercial manufacturing of biologic-based therapies, with demand influenced by the growth and development within the cell and gene therapy industry.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required